Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

Kalaris Therapeutics, Inc.

CIK 0001754068KLRS· quarter ending 2026-06-30
Shares outstanding
23,804,981
Held by 13F filers
18,030,981
75.7% of shares outstanding
Holders
56
-2 vs 2026-03-31 · 9 new, 11 exited
Value
$73.4M
shares -3.7% vs prior quarter

Share classes (cover page of the 10-Q filed 2026-08-11, as of 2026-08-04)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common stockKLRS · NASDAQ23,804,98118,030,98175.7%56482929106

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
482929106COM5618,030,98123,804,98175.7%$73.4M—13DGholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 2 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (56 of 56 · 482929106)

change vs 2026-03-31
#FilerShares% of classValueChange
1SAMSARA BIOCAPITAL, LLC12,881,17554.11%$52.4M-66,906 (-0.5%)
2RTW INVESTMENTS, LP1,300,0005.46%$5.3M—
3Alyeska Investment Group, L.P.572,6872.41%$2.3M—
4Siren, L.L.C.435,7981.83%$1.8M—
5VANGUARD CAPITAL MANAGEMENT LLC398,7121.67%$1.6M+143,364 (+56.1%)
6Ikarian Capital, LLC360,0001.51%$1.5M—
7UBS Group AG262,1311.10%$1.1M+255,947 (+4138.9%)
8RENAISSANCE TECHNOLOGIES LLC149,3510.63%$608K+83,200 (+125.8%)
9MARSHALL WACE, LLP139,2010.58%$567K+71,322 (+105.1%)
10GEODE CAPITAL MANAGEMENT, LLC114,0370.48%$464K+26,492 (+30.3%)
11Woodline Partners LP100,0000.42%$407K—
12ADAR1 Capital Management, LLC100,0000.42%$407K—
13WHI TRUST Co LLC97,4930.41%$397K—
14RAYMOND JAMES FINANCIAL INC97,1640.41%$395K-21,723 (-18.3%)
15CITADEL ADVISORS LLC95,7720.40%$390KNEW
16BOOTHBAY FUND MANAGEMENT, LLC92,2610.39%$376K—
17Verdad Advisers, LP80,2970.34%$327KNEW
18MORGAN STANLEY72,3260.30%$294K+33,982 (+88.6%)
19VANGUARD FIDUCIARY TRUST CO66,1790.28%$269K+29,462 (+80.2%)
20BlackRock, Inc.54,4420.23%$222K+18,399 (+51.0%)
21Fortis Capital Advisors, LLC40,0000.17%$163K—
22Belpointe Asset Management LLC40,0000.17%$163K—
23Pale Fire Capital SE39,6260.17%$161KNEW
24Squarepoint Ops LLC38,7750.16%$158K-998 (-2.5%)
25BRIDGEWAY CAPITAL MANAGEMENT, LLC32,5000.14%$132K+10,000 (+44.4%)
26Stonepine Capital Management, LLC30,1220.13%$123K+9,722 (+47.7%)
27Connor, Clark & Lunn Investment Management Ltd.30,0070.13%$122K+16,352 (+119.8%)
28Trexquant Investment LP29,7370.12%$121KNEW
29STATE STREET CORP26,5100.11%$108K—
30NORTHERN TRUST CORP25,8390.11%$105K+11,390 (+78.8%)
31Velan Capital Investment Management LP25,0000.11%$102K+7,000 (+38.9%)
32TWO SIGMA INVESTMENTS, LP23,8470.10%$97K-6,803 (-22.2%)
33WealthTrust Asset Management, LLC20,4160.09%$83K+8,000 (+64.4%)
34Independent Advisor Alliance18,1250.08%$74K+3,895 (+27.4%)
35RBF Capital, LLC17,3910.07%$71K—
36Quadrature Capital Ltd16,5270.07%$67KNEW
37GOLDMAN SACHS GROUP INC16,0540.07%$65K-94,449 (-85.5%)
38DIMENSIONAL FUND ADVISORS LP15,9580.07%$65KNEW
39SUSQUEHANNA INTERNATIONAL GROUP, LLP14,2210.06%$58K-38,463 (-73.0%)
40HRT FINANCIAL LP13,7230.06%$55K+2,106 (+18.1%)
41NANO CAP NEW MILLENNIUM GROWTH FUND L P12,5000.05%$51K+8,500 (+212.5%)
42Virtu Financial LLC10,8450.05%$44KNEW
43Sigma Planning Corp10,1670.04%$41KNEW
44FMR LLC7,8060.03%$32K—
45Tower Research Capital LLC (TRC)2,5600.01%$10K+2,421 (+1741.7%)
46Steward Partners Investment Advisory, LLC2,2150.01%$9K—
47Vanguard Global Advisers, LLC7250.00%$3K—
48BARCLAYS PLC3030.00%$1K-4,977 (-94.3%)
49Strengthening Families & Communities, LLC2680.00%$1K—
50BNP PARIBAS FINANCIAL MARKETS520.00%$212-600 (-92.0%)
51JPMORGAN CHASE & CO500.00%$211—
52Parallel Advisors, LLC490.00%$199—
53HARBOUR INVESTMENTS, INC.130.00%$53—
54ROYAL BANK OF CANADA120.00%$0-91 (-88.3%)
55Caitong International Asset Management Co., Ltd70.00%$28NEW
56SBI Securities Co., Ltd.50.00%$20—
Exited since 2026-03-31 (11 filers; largest 11 shown)
Paradigm Biocapital Advisors LP−700,000
Propel Bio Management, LLC−295,771
Kalehua Capital Management LLC−271,170
Simplify Asset Management Inc.−87,426
MILLENNIUM MANAGEMENT LLC−59,534
683 Capital Management, LLC−45,000
Qube Research & Technologies Ltd−11,103
Johnson Financial Group, Inc.−10,000
CITIGROUP INC−8,703
Fortitude Family Office, LLC−114
FEDERATED HERMES, INC.−34

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
Samsara BioCapital GP, LLCSCHEDULE 13D/A2026-05-222026-05-2010,671,96544.9%
Srinivas AkkarajuSCHEDULE 13D/A2026-05-222026-05-2012,900,58354.2%
Samsara Opportunity Fund, L.P.SCHEDULE 13D/A2026-05-222026-05-202,224,1479.3%
Samsara Opportunity Fund GP, LLCSCHEDULE 13D/A2026-05-222026-05-202,224,1479.3%
Samsara BioCapital, L.P.SCHEDULE 13D/A2026-05-222026-05-2010,657,02844.8%
Roderick WongSCHEDULE 13G2026-02-172025-12-311,300,0005.7%
RTW Investments, LPSCHEDULE 13G2026-02-172025-12-311,300,0005.7%
Raymond DebbaneSCHEDULE 13G/A2025-07-292025-06-30282,5861.5%
Invus Public Equities, L.P.SCHEDULE 13G/A2025-07-292025-06-30282,5861.5%
Invus Public Equities Advisors, LLCSCHEDULE 13G/A2025-07-292025-06-30282,5861.5%
Invus Global Management, LLCSCHEDULE 13G/A2025-07-292025-06-30282,5861.5%
Siren, L.L.C.SCHEDULE 13G/A2025-07-292025-06-30282,5861.5%
Oleg NodelmanSCHEDULE 13G/A2025-05-152025-03-31201,7181.1%
EcoR1 Capital Fund Qualified, L.P.SCHEDULE 13G/A2025-05-152025-03-31191,2421%
EcoR1 Capital, LLCSCHEDULE 13G/A2025-05-152025-03-31201,7181.1%
GILEAD SCIENCES, INC.SCHEDULE 13G/A2025-03-202025-03-18723,2733.9%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.